Literature DB >> 7053605

Usefulness of the ajmaline test in patients with latent bundle branch block.

P A Chiale, J Przybylski, R A Laiño, M S Halpern, G J Nau, R A Sánchez, J O Lázzari, M V Elizari, M B Rosenbaum.   

Abstract

Twelve patients were studied with intermittent bundle branch block whose conduction disturbance disappeared completely and could no longer be recorded even after provoked changes in heart rate. Premature atrial stimulation and atrial pacing at rapid rates were performed in nine patients; in none of these nine were these procedures able to evoke the complete bundle branch block pattern that all patients exhibited before the spontaneous normalization of conduction. In marked contrast, the administration of ajmaline (1 mg/kg body weight, intravenously in 90 seconds) caused the bundle branch block pattern to reappear in 10 (83.3 percent) of the 12 patients 30 to 120 seconds after the end of the injection, and in 11 patients (91.6 percent) when additional atrial stimulation was performed in 1 of the 2 "failures." This pharmacologic test was much more rapid and simple than electrophysiologic testing and it was noninvasive. Results of this study suggest that some form of subclinical fascicular injury was present (or had persisted) at a time when intraventricular conduction was persistently normal even though no significant physiologic alteration could be demonstrated by the atrial stimulation techniques. The ajmaline test may become a valuable tool for uncovering cases of latent bundle branch block and furthering our knowledge of the early natural history of intraventricular block.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7053605     DOI: 10.1016/0002-9149(82)90272-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Ajmaline Challenge To Unmask Infrahisian Disease In Patients With Recurrent And Unexplained Syncope, Preserved Ejection Fraction, With Or Without Conduction Abnormalities On Surface ECG.

Authors:  Francesco Pentimalli; Luca Bacino; Matteo Ghione; Siri Giambattista; Massimo Gazzarata; Paolo Bellotti
Journal:  J Atr Fibrillation       Date:  2016-08-31

2.  Pharmacokinetics and antiarrhythmic efficacy of intravenous ajmaline in ventricular arrhythmia of acute onset.

Authors:  C Köppel; A Wagemann; F Martens
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Apr-Jun       Impact factor: 2.441

3.  The ajmaline test as a method to disclose latent experimental Chagas' heart disease.

Authors:  R B Bestetti; E G Soares; V N Sales-Neto; J S Oliveira
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

4.  Advanced management of ventricular arrhythmias in chronic Chagas cardiomyopathy.

Authors:  David Santacruz; Fernando Rosas; Carina Abigail Hardy; Diego Ospina; Andrea Nathalie Rosas; Juan Manuel Camargo; Juan José Bermúdez; Juan Felipe Betancourt; Víctor Manuel Velasco; Mario D González
Journal:  Heart Rhythm O2       Date:  2021-12-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.